Patent Assignment
Reel/Frame 074693/0867
Assignment of Assignor's Interest
Recorded: 2026-05-19
Received: 2026-05-19
Pages: 11
Assignor
GRUNENTHAL GMBH
Executed: 2021-04-19
Assignee
ADNEURIS THERAPEUTICS, INC.
2031 US HIGHWAY 130, MONMOUTH JUNCTION, NJ, 08852, UNITED STATES
Covered Properties
(21)
Titration of Cebranopadol
Application:
18/933,387 →
Titration of Cebranopadol
Application:
17/557,987 →
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro [Cyclohexane-1,1'-Pyrano-[3,4,B]Indol]-4-Amine and Paracetamol or Propacetamol
Application:
16/502,651 →
Titration of Cebranopadol
Application:
16/116,055 →
Cebranopadol for Treating Pain in Subjects with Impaired Hepatic and/or Impaired Renal Function
Application:
15/545,553 →
Process for the Preparation of 5-Fluorotryptophol
Application:
15/248,553 →
Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or N,N-Dimethyl-)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,b]Indol]-4-Amine
Application:
15/245,626 →
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano-[3,4,B]Indol]-4-Amine and a Propionic Acid Derivative
Application:
15/075,606 →
Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
Application:
15/070,797 →
Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or N,N-Dimethyl-)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,b]Indol]-4-Amine
Application:
14/579,401 →
Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
Application:
13/892,362 →
Pharmaceutical Composition Comprising (1r,4r)-6'-flouro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
Application:
13/892,786 →
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4'9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,B]Indol]-4-Amine and a Gabapentinoid
Application:
13/892,968 →
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,B]Indol]-4-Amine and a Nsar
Application:
13/892,732 →
Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
Application:
13/835,298 →
Crystalline (1r, 4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
Application:
13/736,565 →
Solid forms of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3' H-spiro-[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine hydrochloride
Application:
13/711,277 →
Solid Forms of (1 R,4R)-6' -Fluoro-(N, N-Dimethyl)-4-Phenyl-4' ,9'-Dihydro-3'H-Spiro[ Cyclohexane-1,1 '-Pyrano-[3,4,B]Indol]-4-Amine and Sulfuric Acid
Application:
13/711,375 →
Process for the Preparation of (1R,4R)-6'-Fluoro-(N,N-Dimethyl- and N-Methyl)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano-[3,4,B]Indol]-4-Amine
Application:
13/711,455 →
Crystalline (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,B]Indol]-4-Amine
Application:
13/542,809 →
Method for Synthesizing Substituted Aminocyclohexanone Compounds
Application:
13/313,902 →